SCHEMBL2879097

SCHEMBL2879097

c1cc(-c2ccncc2CN2CCOCC2)c2sccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.40
CNR1 P21554 1/20 0.38
CYP2A13 Q16696 5/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PIK3CA P42336 2/20 0.37
PIK3C2B O00750 1/20 0.36
PDE10A Q9Y233 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1338078 0.82 CYP2A13 (0.40) CXCR4KDM4EALDH1A1HTTCYP2A13
SCHEMBL3632409 0.74 ATR (0.36) LMNAKMT2ACYP2C9
SCHEMBL3632602 0.74 GRK2 (0.36) KDM4E
SCHEMBL2878614 0.73 JAK2 (0.37) CYP2A13ADORA2AADORA1
SCHEMBL3627332 0.68 TRPV1 (0.37) KDM4EALDH1A1LMNAMAPTADORA2A
SCHEMBL1338861 0.68 CYP2A13 (0.61) CXCR4ALDH1A1CYP2A13CYP2C9ALOX15
SCHEMBL14830903 0.67 CYP17A1 (0.53)
SCHEMBL593920 0.66 CYP2A6 (0.55) MAPTHSD17B10
SCHEMBL3632407 0.66 AOC1 (0.40) KDM4EMAPTKMT2AADORA2AADORA1
SCHEMBL4732925 0.65 CYP2C9 (0.57) CXCR4KDM4EALDH1A1CYP2A13LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125794-B1 IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2010-10-20 EP disclosed